Various neurological and psychiatric diseases lead to alterations in cortical serotonergic activity as one of their underlying processes. However, the electrophysiological implication of changes in serotonergic activity remains a matter of investigation. In this study, we investigated whether brain serotonergic activity influences the excitability-related phenomenon known as cortical spreading depression (CSD). CSD parameters (propagation velocity, and amplitude and duration of the DC-shift) was evaluated in rats that received two treatments that increased cortical serotonergic activity, electrical stimulation of the raphe nuclei and subcutaneous injection of a selective serotonin reuptake inhibitor, sumatriptan. A third group of rats was tested on a low-tryptophan diet rat model of serotonin depletion. Control rats for these three groups received, respectively, sham raphe stimulation, saline injection, and a tryptophansupplemented diet. Compared to controls, electrical stimulation of the raphe nuclei and sumatriptan administration decelerated CSD and increased the duration of the negative DC-shift of CSD, whereas the low-tryptophan diet was associated with significantly accelerated CSD propagation and shortened DC-shift of CSD (p < 0.05). We concluded that serotonergic neurons are very important for stabilizing the delicate equilibrium between excitatory and inhibitory neuronal influences that determines cortical excitability and CSD propagation. Our pharmacological, electrophysiological and dietary data suggest that cortical serotonergic activity negatively modulates CSD propagation in the rat cortex. Reduced central serotonergic activity, as can be observed in several neurological and psychiatric diseases, may constitute a pathological factor for increased sensitivity to CSD.
Introduction
Alterations of the physiological and central action of serotonin are implicated in important human diseases, such as psychic depression (Lieberman et al., 2016) , and brain excitability disorders, such as migraine (Schoenen, 2014) and epilepsy (Buchanan et al., 2014) . Cortical spreading depression (CSD) is a brain depolarizing phenomenon that is influenced by conditions that modify neural excitability (Leão, 1972; Guedes and Cavalheiro, 1997) . CSD has been linked to excitability-related diseases based on sharing common mechanisms (Ferrari et al., 2015; Fabricius et al., 2008; Wei et al., 2014) . Chemical factors, including neurotransmitters, seem to participate in CSD. For example, changes in the brain excitability caused by altering GABAergic (Guedes et al., 1992) or opioidergic mechanisms (Rocha-de-Melo et al., 2008) have been shown to influence CSD propagation. Regarding serotonin, some experimental evidence suggests a relationship between serotonergic drugs and CSD (Marranes et al., 1993; Amâncio-dos-Santos et al., 2006) . In addition, administration of an essential aromatic amino acid, L-tryptophan, which is the precursor for serotonin synthesis (Friedman et al., 1972) , can decrease wakefulness and increase fatigue and lethargy in humans, which is likely due to increased serotonin synthesis with the enhanced tryptophan availability (Leatwood, 1985) . Therefore, alteration in the brain tryptophan availability can influence serotonin synthesis (Fernstrom, 2013) , and Serotonin depletion has been shown to modulate the cerebrovascular responses induced by CSD (Saengjaroentham et al., 2015) . In laboratory animals, pharmacological treatment with serotonergic agonists or antagonists can modify the brain serotonergic activity (Smith et al., 2015) . In addition, electrical stimulation of brain areas that contain serotonergic neurons can enhance serotonergic activity in the target areas in the central nervous system, which has been shown to be associated with changes in behavioral reactions (Mickley et al., 2013; Wscieklica et al., 2017) .
To further investigate the relationship between the brain serotonin activity and CSD, we performed three sets of experiments in rats; these separately involved pharmacological, electrophysiological and dietary experimental approaches. Our results confirm the participation of the serotonergic system in CSD and provide three lines of evidence in favor of the hypothesis that the velocity of CSD propagation inversely correlates with brain serotonergic activity.
Results

Role of electrical stimulation of the raphe nuclei for cortical spreading depression propagation
In the first set of experiments, we tested whether electrical stimulation of the serotonin-containing neurons of the raphe nuclei complex (see methods), which increases the serotonergic activity in the cerebral cortex (Celada et al., 2013) , influenced CSD propagation velocity. After raphe stimulation, the CSD velocity of propagation decreased from a baseline value of 3.36 ± 0.19 mm/ min (n = 7) to 2.75 ± 0.33 mm/min (Fig. 1) , and the duration of the negative DC-changes of CSD increased from a baseline value of 56.5 ± 5.5 s to 76.7 ± 7.5 s (n = 12; p < 0.05, paired t-test). In the control rats, a stimulating electrode was inserted in the raphe nuclei complex, but no electrical stimulation was performed. In these animals, the CSD velocities and durations before and after electrode insertion were similar (velocities: 3.30 ± 0.37 mm/min and 3.29 ± 0.34 mm/min, respectively; durations: 59.3 ± 6.4 s and 61.3 ± 6.3 s, respectively).
Cortical spreading depression propagation with sumatriptan
In addition to an electrical stimulation-induced increase of the serotonergic activity (raphe nuclei electrical stimulation; see above), we performed a second set of experiments to test whether treatment with sumatriptan, a selective serotonin reuptake inhibitor, influenced the CSD propagation velocity in the rat cortex. Fig. 2 presents the CSD velocities in young and adult sumatriptan-treated rats. The saline-injected controls presented with mean velocity of 3.68 ± 0.22 mm/min and 3.39 ± 0.15 mm/min for the young and adult controls, respectively, which had CSD duration of 59.8 ± 6.1 s and 61.0 ± 5.2 s. Compared with the controls, sumatriptan-injected rats displayed significantly lower CSD velocities (3.06 ± 0.30 mm/min and 2.85 ± 0.22 mm/min; p < 0.05) and longer CSD durations (72.5 ± 6.7 s and 74.2 ± 6.1 s; p < 0.05).
Cortical spreading depression propagation after dietary tryptophan depletion
Our results suggested that the propagation velocity of CSD is inversely proportional to the serotonergic activity, which is known Fig. 1 . A and B, recordings of CSD negative slow potential (P) variation in one control rat (that was sham-stimulated; A) and one animal with electrical stimulation of the raphe nuclei (B). The skull diagram indicates the positions of the reference electrode (R), recording electrodes 1 and 2, and place of KCl application to elicit CSD. Note the longer latency (interrupted lines) in the 'raphe stimulation' period in B, which was not observed in A. C, the mean CSD velocity in both groups. * , significantly different from the 'baseline' value (p < 0.05; paired t-test). In A and B, the horizontal bars equal 1 min and correspond to the moment of KCl application. The vertical bars correspond to À10 mV (negative upwards). Recordings of CSD negative slow potential (P) variation (upper panels) in one control rat that received saline and one animal that received sumatriptan via subcutaneous injection. The skull diagram indicates the positions of the reference electrode (R), recording electrodes 1 and 2, and place of KCl application to elicit CSD. The horizontal bars equal 1 min and correspond to the moment of KCl application. The vertical bars correspond to À10 mV (negative upwards). The lower panel presents the mean CSD velocity of propagation in Wistar rats that received saline (control groups; n = 7 and n = 8, respectively, for the young and adult controls) or sumatriptan via subcutaneous injection (60 mg/kg sumatriptan on postnatal days 7, 15, 22 and 30, which was followed by CSD recording on P31-P40; young group, n = 9). Another set of eight rats received 15 mg/kg sumatriptan subcutaneously for 7 consecutive days at adulthood (84-90 days of age), which was followed by electrophysiological recordings of CSD (adult group). The data are expressed as the mean ± standard deviation.
to increase after electrical stimulation of the raphe nuclei and after sumatriptan administration. To further test the hypothesis of an inverse relationship between serotonergic activity and CSD propagation, we analyzed rats that were subjected to dietary tryptophan depletion, which reduces serotonin synthesis (Fernstrom, 2013) . We measured the CSD propagation velocity in rat pups that were suckled by mothers who received a low-tryptophan diet during the lactation period (see methods). CSD was recorded in two ageranges, P25-P30 days and P90-P120 days. In addition, a third group was treated with a low-tryptophan diet at adulthood (70-90 days of age) and was subjected to CSD recording immediately thereafter.
Body and brain weight measurements revealed significantly lower values in the rats whose dams received the lowtryptophan diet during lactation. In the group that received the diet at adulthood, we observed a reduction in the body weight, but there was no reduction in the brain weight ( Fig. 3B and C) . These data indicate the effectiveness of the low-tryptophan diet in affecting weight of the animals compared with the agematched controls. Tryptophan-deficient animals displayed a significant (p < 0.05) increase in the CSD velocity (Fig. 3A) , and a decrease in the duration of the negative DC potential of CSD. The mean values for CSD velocity and duration in the groups treated early in life and recorded at 30-40 days and 90-120 days of life and those treated in adulthood were respectively 3.79 ± 0.20 mm/min, 3.61 ± 0.17 mm/min and 3.76 ± 0.19 mm/ min (velocities), and 46.5 ± 5.2 s, 45.5 ± 5.9 s and 45.1 ± 5.1 s (durations). In the corresponding age-matched control animals, the velocities were respectively 3.28 ± 0.11 mm/min, 3.18 ± 0.08 mm/ min) and 3.26 ± 0.19 mm/min, and the durations were 63.1 ± 6.6 s, 62.7 ± 6.9 s and 62.3 ± 6.1 s (p < 0.05).
Discussion
Our data suggest that brain serotonergic activity constitutes a relevant, modulating factor for the propagation of CSD in the rat cortex. Electrical activation of serotonergic raphe nuclei (Fujiwara et al., 1981; Puig et al., 2010) and pharmacological treatment with sumatriptan (Tokuoka et al., 2015) are two procedures that enhance serotonin activity, and they were associated with slower CSD propagation (Figs. 1 and 2 ) and longer CSD duration in this study. The CSD deceleration effect associated with citalopram was observed both in young and adult brains (Fig. 2) , suggesting that this effect is not significantly influenced by age. The opposite CSD changes were observed in groups subjected to a lowtryptophan diet during the suckling period or at adulthood. This Fig. 3 . Recordings of CSD negative slow potential (P) variation (upper panels) in three control rats and three animals under tryptophan-deficiency. S30 and S90 are groups that were suckled by dams fed a tryptophan-deficient diet during the whole suckling period, and had CSD recorded at postnatal days 30 and 90, respectively. Ad, rats treated with a deficient diet at adulthood. The skull diagram indicates the positions of the reference electrode (R), recording electrodes 1 and 2, and place of KCl application to elicit CSD. The horizontal bars equal 1 min and correspond to the moment of KCl application. The vertical bars correspond to À10 mV (negative upwards). The lower panels (A, B and C) presents mean CSD velocity (A), body weight (B) and brain weight (C). The asterisk indicates a significant difference compared to the corresponding control group that received a tryptophan-supplemented diet (p < 0.05; unpaired t-test).
dietary treatment, which is known to reduce serotonin synthesis (Fernstrom, 2013; Sanchez et al., 2015) and alter brain development (González et al., 2008) and plasticity (Penedo et al., 2009) , impaired body weight gain (see results), accelerated CSD (Fig. 3  C) and shortened the negative CSD DC-signal. Again, we suggest that the age at treatment does not influence CSD effects, as the same CSD accelerating action was observed in groups treated during suckling and at adulthood (Fig. 3) . These findings are in agreement with data from others showing that degeneration of serotonergic neurons in the dorsal raphe nuclei via intracerebroventricular injection of 5,7-dihydroxytryptamine creatinine sulfate accelerates CSD propagation (Cui et al., 2013) . The first indications that serotonin activity may affect CSD are derived from pharmacological studies. Treatment of rats with serotonin activity-enhancers, such as fenfluramine (Cabral-Filho et al., 1995) , citalopram (Guedes et al., 2002) , 2013) . Therefore, it was speculated that brain serotonergic activity may influence CSD propagation in an inverse manner, but other causalities, such as a redox imbalance (Read et al., 1999; Read and Parsons, 2000) , cortical myelination (Merkler et al., 2009) , altered cell-packing density, neuron-to-glia ratio, or synaptic neurotransmitters beyond the serotonergic one (Rocha-de-Melo et al., 2006), were also considered. This last possibility must be considered because Boyer et al. (1998) reported that serotonergic drugs reduce the N-methyl-D-aspartate (NMDA) receptor subunit mRNA level. Interestingly, presynaptic NMDA receptor activation contributes to a cycle of glutamate-induced glutamate release that mediates high potassium-triggered CSD (Zhou et al., 2013) .
It has not been previously investigated in detail how serotonergic-dependent processes modulate CSD propagation. Rather than supporting indirect participation, the present data favor a direct involvement of serotonin activity in CSD propagation because the CSD velocity was modulated in a dichotomous manner, i.e., deceleration in animals receiving serotonin activity enhancing treatments (Figs. 1 and 2 ) and acceleration in serotonin-deficient rats (Fig. 3) . Furthermore, topical cortical application of serotonin agonists reversibly reproduces the CSD decelerating effects of systemic treatment with the same agonists (Amâncio-dos-Santos et al., 2006; Guedes et al., 2002) , suggesting a cortically based mechanism for such an effect. However, we cannot disregard the participation of cortico-subcortical interactions, as has been recently suggested (Toriumi et al., 2016; Shatillo et al., 2013) . Although brain serotonin levels have not presently been measured, it is reasonable to consider the possibility that this transmitter level was modulated in our three models of modifying serotonergic activity. All of the present evidence notwithstanding, measurement of serotonin changes under the here described conditions is needed to confirm the role of serotonin on CSD.
Regarding the clinical relevance of CSD, this excitability-related phenomenon has been associated to important human diseases, such as epilepsy, migraine and traumatic brain injury (Fabricius et al., 2008; Ferrari et al., 2015; Torrente et al., 2014) . For this reason, it is expected that treatments that affect the brain serotonergic activity should modulate those human neurologic disorders (Amâncio-dos-Santos et al., 2006; Chauvel et al., 2017; James et al., 2017) . In a translational view, these findings can help to understand and perhaps develop novel therapeutic strategies for treating the related diseases (Griffin et al., 2017) .
In addition to its modulating action on CSD propagation, cortical serotonergic activity may alter the excitability of the cerebral cortex in an inverse manner (Acler et al., 2009; Mazarati et al., 2008) . Serotonergic cortical neurons appear to substantially contribute to regulating the balance between excitatory and inhibitory neuronal influences that are relevant for cortical excitability and, possibly, for CSD propagation. Furthermore, serotonin-induced changes in inhibitory tonus of the brain, via changes in brain IPSPs, could affect CSD, as demonstrated for the GABA system (Mesgari et al., 2015) . This possibility has to be further investigated.
In summary, our study documents three lines of experimental evidence that demonstrate that cortical serotonergic activity inversely correlates with the CSD propagation velocity in the rat cortex. The following five observations are analyzed in detail. First, animals that received electrical stimulation of the raphe nuclei displayed a reduction in the CSD velocity of propagation compared with the pre-stimulation value in the same animals. Second, sham-control rats that had a stimulating electrode implanted in the raphe nuclei without stimulation did not show changes in the CSD velocity. Third, CSD deceleration was also observed in rats that received subcutaneous injections of a serotonin agonist, sumatriptan. Fourth, the CSD effect of sumatriptan was not influenced by the age at treatment, as we observed the same CSD deceleration in animals that were treated early in life and at adulthood. Fifth, treatment with a tryptophan-deficient diet accelerated CSD propagation, and this effect was also independent of age. In several neurological (Buchanan et al., 2014; Deen et al., 2016; Peričic and Švob-Štrac, 2007) and psychiatric diseases (Garcia-Garcia et al., 2017; Hedlund, 2009; Lieberman et al., 2016) , disturbances in central serotonergic activity can be observed, which may represent one of the factors that modulate cortical susceptibility to CSD.
Experimental procedures
The experiments were conducted in adult male Wistar rats (n = 97) from the colony at our university. The animals were reared in polypropylene cages (51 cm Â 35.5 cm Â 18.5 cm) in a room maintained at 23 ± 1°C with a 12:12-h light:dark cycle (lights on at 7 h a.m.) with food and water ad libitum. The animals were handled in accordance with the norms of the Institutional Ethics Committee for Animal Research of our University, which comply with the ''Principles of Laboratory Animal Care" (National Institutes of Health, Bethesda, USA).
Electrical stimulation of the raphe nuclei
In twelve male Wistar adult rats, while under anesthesia (1 g/kg urethane +40 mg/kg chloralose, i.p.), we recorded CSD for 1-2 h (baseline recording; see below). This was followed by the stereotaxic insertion (AP = À7.8; ML = 0.5; Depth = 5.6) of a bipolar stimulating electrode into the raphe nuclei complex, which was then stimulated for 20 min (1200 square-wave pulses, 100 mA, 1 ms duration, and 1 Hz). After raphe nuclei stimulation, CSD recording continued for 2 h, and we compared the CSD velocity before (baseline) and after raphe electric stimulation. In another control group of 7 animals, a stimulating electrode was inserted into the raphe nuclei complex, but the animals were not electrically stimulated (sham-stimulated group). We only included those animals in which histological examination confirmed that the electrode tip was positioned in the raphe nuclei complex in this study.
Treatment with a selective serotonin reuptake inhibitor, sumatriptan
Nine male Wistar rats received a subcutaneous injection of 60 mg/kg sumatriptan on the postnatal (P) days 7, 15, 22 and 30, which was followed by CSD recording on P31-P40 (young group).
Another set of eight rats received 15 mg/kg sumatriptan subcutaneously for 7 consecutive days at adulthood (84-90 days of age), which was followed by the electrophysiological recordings of CSD (adult group). Two corresponding control groups were injected with saline at the same periods and conditions (n = 7 and n = 8, respectively, for the young and adult groups).
Low-tryptophan diet model
Treatment with a tryptophan-deficient diet was used as a model for reducing brain tryptophan availability, which can diminish serotonin synthesis (Fernstrom, 2013) . Our tryptophandeficient diet was based on two proteins, zein (from corn flour), which is very poor in tryptophan, and gelatin, which is tryptophan-free. Our control diet, which was based on the same proteins, was supplemented with 1% exogenous tryptophan (Gibbons et al., 1979) . Lactating rat dams received the lowtryptophan diet during the entire lactation period, and their progeny (n = 14 animals) were subjected to CSD recording at either 25-30 days of age (young group; n = 8) or at adult life (90-120 days; adult group; n = 6). Another group of 9 adult rats (70-90 days of age) received the tryptophan-deficient diet for 28 days and was subjected to CSD recording immediately after the dietary treatment. These experimental groups were compared with corresponding control groups that received a corn-gelatin diet supplemented with 1% exogenous tryptophan (n = 16 for the group treated during lactation, and n = 7 for the group treated at adulthood).
CSD recording
To record CSD, rats were anesthetized with a mixture of urethane (1 g/kg) and chloralose (0.4 g/kg) (both from SigmaAldrich St Louis, USA). They were then positioned in a stereotactic frame (David Kopf, USA). The body temperature was maintained at 37 ± 1°C. Three 3-mm diameter holes were drilled over the right side of the skull. The center of the holes was 2 mm lateral to the sagittal suture; one hole was 2 mm rostral, and the other two holes were, respectively, 2 mm and 6-7 mm posterior to the coronal suture. Two Ag-AgCl-Agar-Ringer recording electrodes were gently placed onto the dura mater at the two posterior trepanations within a defined interelectrode distance (4-5 mm). A common reference electrode of the same type was mounted on the nasal bone. The rostral trepanation was used to elicit CSD (see skull diagram in Fig. 1 ). CSD was elicited by applying, on the intact dura mater, a cotton ball (1-2 mm diameter) soaked in a 2% KCl solution (approximately 0.27 M), which was prepared by dissolving 2 g of KCl into 100 ml of distilled water. KCl stimulation was always applied to the rostral burr hole for approximately 1 min. CSD propagation was investigated in the frontal-to-occipital direction. The slow direct current (DC) potential change accompanying CSD (Leão, 1947 ) was recorded using a digitalizing system (EMG System Ltd.), which enabled us to measure CSD parameters (amplitude [in mV], duration [in s] and velocity of propagation. The CSD velocity was expressed in millimeters per minute (mm/min) and was calculated based on the time required for a CSD wave to pass the distance between the two epicortical recording electrodes. Over the 4-h recording session, twelve CSDs were usually elicited and recorded in each animal with an interval of 20 min between 2 consecutive elicitations.
Statistics
Data in all groups are expressed as the means ± standard deviations. Data were analyzed using Sigmastat TM software, version 3.10. Statistical analysis was performed with the paired t test, if intraindividual corresponding controls were used, or the unpaired t test, if two independent groups were compared. A p value <0.05 was considered significant.
